Dogwood Therapeutics
DWTX
24 hedge funds and large institutions have $180K invested in Dogwood Therapeutics in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 4 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
0.01% more ownership
Funds ownership: 0.14% → 0.15% (+0.01%)
0% more funds holding
Funds holding: 24 → 24 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
15% less capital invested
Capital invested by funds: $212K → $180K (-$31.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.7K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$11.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.11K |
| 4 |
Jane Street
New York
|
+$5.81K |
| 5 |
HF
HRT Financial
New York
|
+$4.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14.2K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$9.17K |
| 3 |
MCG
McCollum Christoferson Group
Amherst,
New York
|
-$4.87K |
| 4 |
VF
Virtu Financial
New York
|
-$3K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$275 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
26
Virtu Financial
New York
| – | -$3K | -474 | Closed |
|
27
Simplex Trading
Chicago,
Illinois
| – | +$21 | +4 | New |
|
DWTX Hedge Fund Activity: Q3 2024 in Review
24 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q3 2024, worth a combined $180K — down 15% from $212K a quarter earlier.
Fund positioning in DWTX was balanced in Q3 2024: 4 funds opened new positions, 4 closed out, 7 added to existing stakes and 3 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $11.7K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $14.2K sold.
- 24 institutional investors held Dogwood Therapeutics (DWTX) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $180K of Dogwood Therapeutics stock for Q3 2024, down 15% quarter-over-quarter.
- 4 funds opened new Dogwood Therapeutics positions in Q3 2024 and 4 closed out, a net change of 0 holders.
- The largest Dogwood Therapeutics buyer in Q3 2024 was Geode Capital Management, an estimated $11.7K added.
- The largest Dogwood Therapeutics seller in Q3 2024 was Susquehanna International Group, an estimated $14.2K sold.
Based on aggregated 13F filings for Q3 2024.